GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a prominent focus in therapeutic studies, largely due to its remarkable impact on managing conditions such as second type diabetes and obesity. Recent research have demonstrated that more than glucose control, GLP-1 medications offer potential for cardiovascular funct